Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae

References

• Westfall JM, Sophocles A, Burggraf H, Ellis S. Manual vacuum aspiration for first-trimester abortion. Arch Fam Med 1998; 7: 559–62.
   PubMedGoogle Scholar
• Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987–1990. Obstet Gynecol 1996; 88: 161–7.
   PubMed Web of Science ®Google Scholar
• Hogue CJ. Impact of abortion on subsequent fecundity. Clin Obstet Gynecol 1986; 13: 95–103.
   Google Scholar
• Ngai SW, Au Yeung KC, Lao T, Ho PC. Oral misoprostol versus gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception 1995; 51: 347–50.
   PubMed Web of Science ®Google Scholar
• Hulka JF, Lefler HT, Anglone A, Lachenbruch PA. A new electronic force monitor to measure factors influencing cervical dilatation for vacuum curettage. Am J Obstet Gynecol 1974; 120: 166–73.
   Google Scholar
• Shultz KF, Grimes DA, Cates WJ. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983; 1: 1182–5.
   Google Scholar
• Grimes DA, Schultz KF, Cates WJ. Prevention of uterine perforation during curettage abortion. J Am Med Assoc 1984; 251: 2108–11.
   Google Scholar
• MacKenzie IZ, Fry A. Prostaglandin E2 pessaries to facilitate first trimester aspiration termination. Br J Obstet Gynaecol 1981; 88: 1033–7.
   PubMedGoogle Scholar
• Molin A. Risk of damage to the cervix by dilatation for first trimester induced abortion by suction aspiration. Gynecol Obstet Invest 1993; 35: 152–4.
   PubMed Web of Science ®Google Scholar
• Karim SM, Filshie GM. Therapeutic abortion using prostaglandin F2a. Lancet 1970; 1: 157–9.
   PubMed Web of Science ®Google Scholar
• Moscary P, Csapo AI. Menstrual induction with PGF2a and PGE2. Prostaglandins 1975; 10: 543–7.
   Google Scholar
• El-Refeay H, Calder L, Wheatley DN, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994; 343: 1207–9.
   Google Scholar
• World Health Organization. Medical methods for termination of pregnancy. WHO Technical Report Series no. 871. Geneva: World Health Organization, 1997.
   Google Scholar
• Wright CSW, Campbell S, Beazley J. Second trimester abortion after vaginal termination of pregnancy. Lancet 1972; 1: 1278–9.
   Google Scholar
• Grimes DA, Cates W. Complications from legally-induced abortion: a review. Obstet Gynecol Surv 1979; 34: 177–91.
   PubMedGoogle Scholar
• Christensen N, Bygdeman M, Gréen K. Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion. Contraception 1983; 27: 51–61.
   Google Scholar
• Fletcher HN, Mitchell S, Simeon D, Frederick J, Brown D. Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynecol 1993; 100: 641–4.
   Google Scholar
• Scientific Advisory Committee of the Royal College of Obstetricians and Gynaecologists. Guidelines on induced abortion. London: Royal College of Obstetricians and Gynaecologists, 1997; 11: 1–10.
   Google Scholar
• Penney GC, Templeton A. Induced abortion: an audit of reported current practice among consultant gynaecologists in Scotland. Br J Obstet Gynaecol 1994; 101: 523–8.
   PubMedGoogle Scholar
• Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241–7.
   PubMed Web of Science ®Google Scholar
• Ngai SW, Tang OS, Lao T. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod 1995; 10: 1220–2.
   Google Scholar
• Lawrie A, Penney G, Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 1117–19.
   Google Scholar
• Bugalho A, Bique C, Almeida L, Bergstrom S. Application of vaginal misoprostol before cervical dilatation to facilitate firsttrimester pregnancy interruption. Obstet Gynecol 1994; 83: 729–31.
   PubMed Web of Science ®Google Scholar
• Bokstrom H, Atterfelt P, Alexandersson M, Brannstrom M, Norstrom A. Preoperative cervical softening before first trimester legal abortion by mifepristone and misoprostol. A double-blind, randomized, clinical biochemical and immunohistochemical study. Contraception 1998; 58: 157–63.
   Google Scholar
• De Jonge ET, Jewkes R, Levin J, Rees H. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester. S Afr Med J 2000; 90: 256–62.
   Google Scholar
• Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol 1996; 103: 1120–3.
   PubMedGoogle Scholar
• Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000; 183: 998–1002.
   Google Scholar
• MacIsaac L, Grossman D, Balistreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol 1999; 93: 766–70.
   PubMed Web of Science ®Google Scholar
• Fong YF, Singh K, Prasad RN. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for preoperative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol 1998; 105: 413–7.
   Google Scholar
• Zikopuolos KA, Papanikolau EG, Kalantaridou SN, Tsanadis GD, Plachouras NI, Dalkalitsis NA et al. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Hum Reprod 2002; 17: 3079–83.
   Google Scholar
• Baird DT, Sukcharoen N, Thong KJ. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 1995; 10: 1521–7.
   Google Scholar
• Collins PW. Misoprostol: discovery, development, and clinical applications. Med Res Rev 1990; 10: 149–72.
   Google Scholar
• Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88–92.
   Google Scholar